Back to User profile » Dr Ryusuke Hatae
Papers published by Dr Ryusuke Hatae:
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Add-on bevacizumab can prevent early clinical deterioration and prolong survival in newly diagnosed partially resected glioblastoma patients with a poor performance status
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Sangatsuda Y, Suzuki SO, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2017, 10:429-437
Published Date: 18 January 2017
Original Research
![Highly-accessed](assets/img/article_icons/highly-accessed.png)
Deferred radiotherapy and upfront procarbazine–ACNU–vincristine administration for 1p19q codeleted oligodendroglial tumors are associated with favorable outcome without compromising patient performance, regardless of WHO grade
Hata N, Yoshimoto K, Hatae R, Kuga D, Akagi Y, Suzuki SO, Iwaki T, Shono T, Mizoguchi M, Iihara K
OncoTargets and Therapy 2016, 9:7123-7131
Published Date: 17 November 2016